Dengue: Breakbone fever, hemorrhagia or shock

Journal of Health and Translational Medicine

Volumn 11, Issue 2, 2008, Pages 39-52

  Shamala, D ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Dengue; Dengue haemorrhagic fever; Laboratory diagnosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA TUBULIN; ANTIVIRUS AGENT; CHIMERIVAX; CYTOKINE; DENGUE VACCINE; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN M ANTIBODY; LIVE VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; SMALL INTERFERING RNA; THIOREDOXIN; UNCLASSIFIED DRUG;

AEDES AEGYPTI; BRAIN DISEASE; CARDIOMYOPATHY; CLINICAL FEATURE; CLINICAL TRIAL; COMA; CONVULSION; DENGUE; DENGUE VIRUS; DIAGNOSTIC PROCEDURE; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; GROUPS BY AGE; HEMATURIA; HEMORRHAGIC SHOCK; HLA SYSTEM; HUMAN; HYPERMENORRHEA; HYPOALBUMINEMIA; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LEUKOPENIA; LIVER INJURY; NONHUMAN; PETECHIA; POPULATION DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; T LYMPHOCYTE; THROMBOCYTOPENIA; VALIDATION PROCESS; VIREMIA; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 77953448764     PISSN: 18237339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: The emergence of a global health problem. Emerging Infectious Diseases 1995; 1 (2): 55-57.
2. Gubler DJ. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann. Acad Med Singapore 1998; 27: 227-234.
3. Rigau-Pérez JG, Gubler DJ, Clark GG, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever surveillance. Lancet 1998; 352: 971-977.
4. World Health Organization fact Sheet No. 117. April 2002. Geneva.
5. Skae FMT. Dengue fever in Penang. Brit Med J 1902; 2:1581-1590.
6. Smith CGE. The history of dengue in tropical Asia and its probable relationship to the mosquito Aedes aegypti. J Trop Med Hyg 1956; 59:3-8.
7. Smith CEG. Isolation of three strains of type 1 dengue virus from a local outbreak of the disease in Malaysia. J of Hygiene 1956; 54: 569-580.
8. Wallace HG, Lim TH, Rudnick A, Knudsen AB, Cheong WM, Chew V. Dengue haemorrhagic fever in Malaysia: The 1973 epidemic. Southeast Asian J Trop Med Pub Hlth 1980; 11:1-13.
9. Shekhar KC, Ong LH. Epdemiology of dengue/dengue haemorrhagic fever in Malaysia - a retrospective epidemiological study, 1973-1987. Part II: Dengue Fever (DF). Asia Pacific J Pub Hlth 1992; 6:126-133.
10. Shekhar KC, Senan P. Epdemiology of dengue/dengue haemorrhagic fever in Malaysia III. A comparative study of clinical features seen in virologically confirmed cases for periods between 1963-1987 - a review. J Singapore Paediatric Soc 1992; 34: 67-82.
11. WHO Collaborating Centre for Arbovirus Reference and Research (DF/DHF) Malaysia. Annual report; 2006.
12. Leontsini E, Gil E, Kendall C, Clark GG. Effect of a community based Ae. Aegypti control programme on mosquito larval production sites in El Progreso, Honduras. Trans R Soc Trop. Med Hyg 1993; 87: 267-271.
13. Gubler DJ, Clark GG. Community-based integrated control of Aedes aegypti: a brief overview of current programs. Am J Trop Med Hyg 1994:50:50-60.
14. George R, et al. Changing pattern in the clinical presentation of dengue hemorrhagic fever in Malaysia during the period 1962-1982. J Malaysian Soc Hlth 1984; 4:57-64.
15. George R. Dengue hemorrhagic fever in Malaysia (a review). South-east Asian J Trop Med Pub Hlth 1987; 18:278-283.
16. Srichakul T, et al. Fibrinogen metabolism and the disseminated intravascular coagulation on dengue haemorrhagic fever. 1977; 26:525-532
17. Kliks SC, Nimmantiya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38 (2): 411-419.
18. Lum LCS, Lam SK, George R, Devi S. Fulminant hepatitis and encephalopathy in dengue infection. South-east Asian J Trop Med Pub Hlth 1993; 24:467-471.
19. Halstead SB. Antibody, macrophages, dengue virus infection, shock and hemorrhage: A pathogenesis cascade. Rev Inf Dis 1989: 11: S830-839.
20. Dengue Haemorrhagic Fever: Diagnosis, treatment, prevention and control, 2nd ed. WHO, Geneva, Switzerland; 1977.
21. Brown JL, Wilkinson R, Davidson RN. Rapid diagnosis and determination of duration of viremia in dengue fever using polymerase chain reaction. Trans R Soc Trop Med Hyg 1996; 90: 140-43.
22. Lam SK, Devi S, Pang T. Detection of specific IgM to dengue infections. South-east Asian J Trop Med Pub Hlth 1987; 18 (14): 532-538.
23. Lam SK, Devi S. Further evaluation on the Dengue IgM ELISA. Arbovirus Information Exchange 1990; 203.
24. Devi S, Ew CL, Subramaniam G. Evaluation of a Dengue NS1 capture ELISA assay for the rapid detection of Dengue. J Infect Dev Countries 2007; 1 (2):140-145.
25. Devi S, Artsorb H. Molecular diagnostics for the detection of flavivirus infections. Exp Opi Med Diag 2007; 1: 51-60.
26. Kuberski, Rosen L, Reed D, Mataika J. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infection with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg 1977; 26 (4): 775-783.
27. Lee HL, et. al. transovarial transmission of dengue virus in Aedes aegypti and Aedes albopictus in relation to dengue outbreak in an urban area in Malaysia. Dengue Bulletin 2005; 29: 106-111.
28. Edelman R. Dengue vaccines approach the finish line - review. Clin Infect Dis 2007; 45 (Suppl 1): S56-60.
29. Schul W, Lin W, Xu HY, Flamond M, Vasudevan SG. A dengue fever viremia model in mice shows reduction in viral amplification and suppression of the inflammatory response after treatment with antiviral drugs. J of Infect Dis 2007; 195: 665-674.
30. Ono L, Wagner W, Iray MR, Terezinha LM, Coimbra, Philip AJG, Sierakowski MR. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BEH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res 2003, 60: 201-208.
31. Pang T, Yap KL, Devi S, Wong PY. Delayed-type hepersensitivity (DTH) response to dengue virus infection in mice: Effect of route of sensitisation and splenectomy. Microbial Immunol 1983; 27 (II): 945-951.
32. Pang T, Devi S, Wong PY, Mackenzie JFC, Yap KL. Ly phenotype and H-2 compatibility requirements of effector cells in the delayed-type hypersensitivity response to dengue virus infection. Infect Immunol 1984; 4: 429-431.
33. Wong PY, Devi S, Mackenzie JFC, Yap KL, Pang T. Induction and Ly phenotype of suppressor cells in mice during primary infection with dengue virus. Immunol 1984; 51: 51-56.
34. Devi S, Wong PY, Manickam L, Bomford R, Pang T, Dhaliwal SS. Effect of various adjuvants on the delayed-type hypersensitivity (DTH) response in experimental dengue infection. Trop Biomed 1985; 2: 6-11.
35. Pang T, Devi S, Blanden RV, Lam SK. T Cellmedicated cytotoxicity against Dengue-infected target cells. Microbiol Immunol 1988; 32 (5): 511-518.
36. Lam SK, Devi S, Pang T, Paul V, Teo L. Epidemiology of dengue in Malaysia in 1988. Dengue Newsletter 1990; 16: 35-40.
37. Lam SK, Devi S. Epidemiology of dengue in Malaysia. Dengue Newsletter, 16: 32.
38. Rajamani R, Nadia A, Devi S. Biological activities of dengue virus in mouse peritoneal cells. JUMMEC 1997; 2 (1): 11-17.
39. Harris E, Holden KL, Edgil D, Polacek C, Clyde K. Molecular biology of flaviviruses. Novartis Found Symp 2006; 23-39.
40. Yong YK, Chong HT, Tan CT, Devi S. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan Real-Time one-step RT-PCR. J Virol Methods 2006; 138: 123-130.
41. Yong YK, Thayan R, Chong HT, Tan CT, Devi S. Rapid detection and serotyping of dengue virus by Multiplex RT-PCR and Real-Time SYBR Green RT- PCR. Sing Med Journal 2007; 48 (7): 662-668.
42. Thayan R, Tan LH, Lum CS, Tan PL, Shahidah N, Rohana Y, Devi S. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. In Trans Royal Soc Trop Med Hygiene; 2008.
43. Thayan R, Tan LH, Lum CS, Norshahidah K, Rohana Y, Devi S. Differential expression of aldolase, alpha tubulin and thioredoxin peroxidase in peripheral blood mononuclear cells from dengue fever and dengue hemorrhagic fever patients. Southeast Asian J Trop Med Hlth 2009; 40 (1): 56-65.
44. Appanna R, Tan LH, Lum CS, Tan PL, Vadivelu J, Devi S. Cross-reactive T cell responses to the non-structural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clinic Vacc Immunol 2007; 14 (8): 969-977.
45. Osmali O, Fong MY, Devi S. A preliminary study of dengue infection in Brunei. Jap J Infect Dis 2007; 4: 205-208.
46. Osmali O, Fong MY, Devi S. Sequence analysis of the E/NS1 gene junction of dengue virus type 2 isolated in Brunei. Southeast Asian J Trop Med Hlth 2008; 39 (1): 62-78.
47. Osmali O, Fong MY, Devi S. Complete genome sequence analysis of dengue virus type 2 isolated in Brunei. Virus Research 2008;135 (1):48-52..
48. Crill WD, Gwong-Jen LC. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 2004; 78 (24): 13975-13986.
49. Yorgo M, Ogata S, Clement D, Harrison SC. Structure of dengue virus proteins after membrane fusion. Nature 2004; 427:313-319.
50. Kuruvilla JG, Troyer RM, Devi S, Akkina R. Dengue virus infection and immune response in humanized RAG2-/-?c-/- (RAG-hu) mice. Virology 369 (1): 143-152.